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Abstract Na+-dependent, high-affinity choline uptake in cho-
linergic neurons is the rate-limiting step in acetylcholine
synthesis. Here we report the molecular cloning and functional
characterization of the human high-affinity choline transporter
(hCHT1). The hCHT1 exhibits significant homology with known
members of the Na+-dependent glucose transporter family, but
not with members of the neurotransmitter transporter family.
The human CHT1 gene is 25 kb in length with 9 exons and was
assigned to chromosome II at position IIq11^12. Northern blot
analysis showed that a 5.4 kb hCHT1 transcript was expressed
exclusively in tissues containing cholinergic neurons. When
expressed in Xenopus oocytes, the human clone induced Na+-
and Cl^-dependent, high-affinity choline uptake, which was
sensitive to the specific inhibitor hemicholinium-3, with a Ki of
1.3 nM. The hCHT1-mediated choline uptake increased with
increasing concentrations of choline, Na+ and Cl^, with EC50
values of 2.0 WM, 76 mM, and 48 mM, and with apparent Hill
coefficients of 1, 2.5 and 2.3, respectively. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Choline is the precursor of membrane lipids such as phos-
phatidylcholine and sphingomyelin, signaling lipids like plate-
let-activating factor and sphingosylphosphorylcholine, and the
neurotransmitter acetylcholine. Choline is an essential nu-
trient and plays a critical role in the development and function
of the brain [1^3]. Choline does not permeate cell membranes
and therefore requires a carrier-mediated transport system to
cross the plasma membrane.
The high-a⁄nity choline transport system has been charac-
terized in brain synaptosomes [4^9], and is thought to be
unique to cholinergic neurons [9,10]. In cholinergic neurons,
choline used in the acetylcholine synthesis is taken up by a
high-a⁄nity choline transporter (CHT) localized in the pre-
synaptic terminals. This high-a⁄nity choline uptake is Na-
dependent, sensitive to hemicholinium-3 (HC3) and is thought
to be the rate-limiting step in acetylcholine synthesis [4^9].
Studies using brain proteoliposomes have demonstrated that
the membrane potential and Na gradient provide the driving
force for high-a⁄nity choline uptake [8,11^13].
The CHT was not identi¢ed in molecular terms for a long
time, in spite of the fact that cDNAs for most of the neuro-
transmitter transporters had been identi¢ed by homology or
expression cloning. Very recently, we succeeded in isolating a
cDNA encoding the CHT1 of the nematode Caenorhabditis
elegans using information provided by the C. elegans Genome
Project and used this cDNA to isolate the rat homolog [14].
The amino acid sequence of CHT1 tuned out to have signi¢-
cant homology with known members of the Na-dependent
glucose transporter family [15], but no signi¢cant homology
with neurotransmitter transporters [16]. The characteristics of
CHT1-mediated choline uptake were essentially the same as
those of the high-a⁄nity choline uptake in rat brain synapto-
somes, showing a high a⁄nity for choline, Na- and Cl3-
dependency, and high sensitivity to HC3.
Cholinergic neurons are known to be selectively degener-
ated in Alzheimer’s disease, resulting in the loss of high-a⁄n-
ity choline uptake activity overall [17]. High-a⁄nity choline
uptake activity and HC3-binding activity, however, are re-
ported to increase in spared nerve terminals in Alzheimer’s
disease patients [18,19]. It will be interesting to examine
whether human CHT (hCHT) is overexpressed under these
circumstances. However, no molecular information on the
human transporter precludes the detailed examination of its
regulation in cholinergic neurons.
In this study, we report the molecular cloning and func-
tional characterization of a cDNA encoding the hCHT1.
We have analyzed the hCHT1-mediated choline uptake to
determine whether the hCHT1 shows choline uptake activity
with the same characteristics as that found in cholinergic
nerve terminals in human.
2. Materials and methods
2.1. Cloning of hCHT1 cDNA
Gene-speci¢c primers were designed based on an entry (GenBank
accession number AQ316435) that is homologous to C. elegans CHT1
(CHO-1) in the human genomic survey sequence (GSS). For primary
5P and 3P rapid ampli¢cation of cDNA ends (RACE), a gene-speci¢c
primer was paired with adapter primer to amplify human brain Mar-
athon Ready1 cDNA (Clontech). This polymerase chain reaction
product was used for secondary RACE reactions using a nested
gene-speci¢c primer. All RACE products were subcloned into
pT7Blue T-Vector (Novagen) and sequenced. A human spinal cord
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Fig. 1. Primary structure and genomic organization of hCHT1. A: Alignment of the predicted amino acid sequence of hCHT1 with rat CHT1
and C. elegans CHO-1. Numbers in the right column correspond to amino acid residues. Identical residues are in bold. The putative transmem-
brane domains I^XII are underlined. B: Structural organization of the hCHT1 gene and its organizational relationship to the hCHT1 cDNA.
Alignment of the cDNA sequence with the genomic sequences (GenBank accession numbers AC009963 and AC023672) predicts nine exons.
Black boxes in the gene represent the coding regions, and open boxes represent untranslated regions. The numbers in cDNA correspond to the
position of the ¢rst nucleotide of each codon.
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cDNA library was constructed using Superscript1 Plasmid System
(Gibco BRL, Life Technologies). The hCHT1 cDNA was isolated
from the cDNA library using the GeneTrapper cDNA Positive Selec-
tion System (Gibco BRL, Life Technologies), in which single strand
cDNA clones hybridized with a biotinylated oligonucleotide probe are
captured on streptavidin-coated paramagnetic beads, repaired and
ampli¢ed. After characterization of the resulting cDNA clones, one
positive clone was subcloned into the NcoI (¢lled-in) and NotI sites of
modi¢ed pSPUTK (Stratagene).
2.2. Northern blotting analysis
Human multiple tissue Northern blots (Clontech) were used for
Northern analysis. The SphI^StuI fragment of hCHT1 cDNA corre-
sponding to 936^1958 bp was labeled with 32P using rediprime1 II
(Amersham Pharmacia Biotech). Filters were hybridized with the
cDNA probe as described [14] and exposed to autoradiography ¢lm
with an enhancing screen for 4 days at 380‡C.
2.3. Expression in Xenopus oocytes
Xenopus laevis oocyte expression studies and uptake measurements
were performed using [3H]choline chloride (83 Ci/mmol) (Amersham
Pharmacia Biotech) as described previously [14]. The hCHT1 cRNA
(25 ng) was injected into manually defolliculated Xenopus oocytes.
Two days after injection, choline uptake assays were performed by
incubating 6^8 oocytes with [3H]choline chloride in 0.75^1.0 ml of
standard uptake bu¡er [14]. Because choline uptake mediated by
hCHT1 was linearly dependent on the incubation time up to 60 min
at the choline concentrations of 10 WM, uptake experiments were
performed for 20 min in most cases. Uptake was terminated by wash-
ing oocytes with 3 ml of ice-cold uptake bu¡er ¢ve times. Non-speci¢c
choline uptake was determined from uptake in the presence of 1 WM
HC3 (Sigma) or from uptake in water-injected oocytes. Each data for
a single oocyte was represented by the mean þ S.E.M. (n = 6^8).
2.4. Ligand binding
A binding assay of [3H]HC3 was carried out using intact Xenopus
oocytes (HC3, 128 Ci/mmol, NEN Life Science Products). Two days
after injection of cRNA, the [3H]HC3 binding assay was performed
using 3^5 oocytes in a ¢nal volume of 500 Wl of standard uptake
bu¡er containing indicated concentrations of [3H]HC3. Binding was
terminated after 1 h at room temperature by washing oocytes with
3 ml of ice-cold standard uptake bu¡er three times. Speci¢c binding was
calculated by subtracting non-speci¢c binding, which was determined
from the binding in the presence of 1 WM HC3, from total binding.
Each data for a single oocyte was represented by the mean þ S.E.M.
(n = 3^5). The turnover number for hCHT1 was calculated by dividing
the Vmax of hCHT1-mediated choline uptake by the Bmax of HC3
binding sites.
3. Results and discussion
3.1. Cloning of hCHT1 cDNA
Recently, we isolated a cDNA encoding the CHT1 from the
nematode C. elegans (CHO-1) [14]. A database search using
the predicted amino acid sequence of C. elegans CHO-1 iden-
ti¢ed an entry (GenBank accession number AQ316435) in the
human GSS. The nucleotide sequence of this GSS entry was
used to isolate the corresponding cDNA from the human
spinal cord. We constructed and screened a human spinal
cord cDNA library and isolated positive clones, one of which
was chosen for further characterization. This cDNA clone was
designated hCHT1.
The hCHT1 cDNA is 5144 bp long with an open reading
frame of 1743 bp (including the termination codon), encoding
a protein of 580 amino acids with a predicted molecular
weight of 63 kDa, containing 12 putative transmembrane do-
mains. The hCHT1 is 93% homologous to the rat CHT1 and
53% homologous to the C. elegans CHO-1 (Fig. 1A). The
amino acid sequence of hCHT1 has signi¢cant homology
(20^26%) with known members of the Na-dependent glucose
transporter family [15], but not with neurotransmitter trans-
porters [16].
A query of GenBank databases revealed human genomic
sequences (GenBank accession numbers AC009963 and
AC023672) that were identical to the hCHT1. Alignment of
these sequences with the cloned cDNA predicts the hCHT1
Fig. 2. Tissue distribution of hCHT1. Northern analysis of CHT1
mRNA transcripts in human tissues probed with 32P-labeled CHT1
cDNA. The hybridization washes were done under high stringency
conditions. The sizes of the molecular weight standards are indi-
cated on the left. The arrowhead indicates positive signals.
Table 1
Ionic dependence of hCHT1-mediated choline uptake
Inorganic salts hCHT1-mediated choline uptake
(fmol/oocyte/30 min)
Percent control
(fmol/oocyte/30 min)
NaCl 5.6 þ 0.2 100 þ 4.4
LiCl 6 0.1 6 1
KCl 6 0.1 6 1
RbCl 6 0.1 6 1
N-Methyl-D-glucamine Cl 6 0.1 6 1
NaBr 3.9 þ 0.1 69.3 þ 2.6
NaF 0.8 þ 0.1 14.3 þ 1.4
NaI 0.8 þ 0.1 14.4 þ 2.2
Na gluconate 0.4 þ 0.1 7.4 þ 1.6
Xenopus oocytes injected with either hCHT1 cRNA or water were incubated with 10 mM [3H]choline for 30 min at room temperature either in
standard bu¡er (100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris, pH 7.4) or in bu¡ers where NaCl was
replaced with various inorganic salts. After incubation, the oocytes were washed with the respective bu¡er (ice cold), and the radioactivity asso-
ciated with the oocytes was determined. Uptake measured in water-injected oocytes was subtracted to obtain hCHT1-mediated uptake. Values
are means þ S.E.M.
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gene structure. The hCHT1 gene is 25 kb in length and con-
tains nine exons (Fig. 1B). The genomic sequences were as-
signed to chromosome II at position IIq11^12.
3.2. Tissue distribution of hCHT1 expression
Tissue distribution of hCHT1 mRNA was studied using
commercially available membrane blots containing size frac-
tionated poly(A) RNA from human tissues. Northern blot
analysis for hCHT1 mRNA showed the expression of a 5.4 kb
transcript (Fig. 2). Expression of hCHT1 mRNA was detected
in putamen, medulla and spinal cord. These regions are
known to contain cholinergic neurons. On the other hand,
no transcripts were detected in other areas of the brain or
non-neuronal tissues examined. This tissue distribution of
hCHT1 mRNA is virtually the same as that of rat CHT1
mRNA [14], indicating that hCHT1 mRNA is expressed ex-
clusively in cholinergic neurons.
3.3. Functional characterization of hCHT1
Choline uptake mediated by hCHT1 was characterized by
expressing it in Xenopus oocytes. The choline uptake in oo-
cytes injected with hCHT1 cRNA was 2^4-fold greater than
the background uptake in oocytes injected with water (Fig.
3A). The hCHT1-mediated choline uptake was inhibited by
HC3 [22] with a Ki of 1.3 nM (Fig. 3B), which is similar to the
value for rat CHT1 (Ki ; 2^5 nM). These values are 10-fold
lower than those in rat brain synaptosomes (5^100 nM) [6^
8,20]. The ionic dependence of the hCHT1-mediated uptake
was examined by measuring choline uptake in hCHT1 cRNA-
and water-injected oocytes in the presence of various inor-
ganic salts (Table 1). Control uptake was measured in the
presence of 100 mM NaCl. The replacement of Na with
other cations such as Li, K or Rb almost completely
abolished the hCHT1-mediated choline uptake, indicating
that Na is obligatory for the uptake function. Replacing
Cl3 with other anions also reduced the CHT1-mediated up-
take, although Br3 could partially substitute for Cl3 as the
counter anion for Na as previously observed for rat brain
synaptosomes [21,22]. Thus, CHT1-mediated choline uptake is
both Na- and Cl3-dependent. The CHT1-mediated choline
uptake saturated with increasing concentrations of choline
with a Km of 2.0 WM, and Vmax of 15^40 fmol/oocyte/min
(Fig. 3C). The determined Km value was similar to that for
rat CHT1 (2.2 WM) and for rat brain synaptosomes (0.5^5
WM) [5^8]. We examined [3H]HC3 binding in intact oocytes,
using the same batch as one used for choline uptake. Speci¢c
Fig. 3. Functional expression of hCHT1 in Xenopus oocytes. A: [3H]Choline uptake into Xenopus oocytes injected with hCHT1 cRNA or
water. Filled and open bars indicate choline uptake measured in the absence or presence of 1 WM HC3, respectively. Each bar represents the
mean þ S.E.M. (n = 6^8 oocytes). Two days after injection of capped cRNA, choline uptake was measured by incubating 6^8 oocytes with
[3H]choline chloride for 20 min in 0.75 ml of standard uptake bu¡er (100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES,
5 mM Tris, pH 7.4). B: Inhibition by HC3 of choline uptake. Choline uptake was measured in the presence of the indicated concentrations of
HC3. C: E¡ect of choline concentration on CHT1-mediated choline uptake. Choline uptake in the presence of 1 WM HC3 was subtracted from
that in the absence of 1 WM HC3, yielding hCHT1-mediated choline uptake. The uptake was ¢tted to a Michaelis^Menten curve. D: Saturation
analysis of speci¢c [3H]HC3 binding in intact oocytes. Speci¢c binding was calculated by subtracting non-speci¢c binding, which was deter-
mined from the binding in the presence of 1 WM HC3, from total binding.
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[3H]HC3 binding was detected in oocytes injected with
hCHT1 cRNA, but not in oocytes injected with water. The
equilibrium dissociation constant (Kd) was estimated to be
6 nM and Bmax was 1^5 fmol/oocyte (Fig. 3D). The calculated
Kd value was similar to those obtained by the binding in
human brain synaptosomes (5^10 nM) [23,24]. Assuming
that one speci¢c HC3 binding site corresponds to one func-
tional CHT, we estimated the apparent turnover number for
hCHT1 to be 0.1^0.2 choline molecule/s at room temperature.
This value is lower than the one (3/s at 20‡C) reported for
synaptosomal membranes from Torpedo electric organ [25].
This di¡erence may indicate that the hCHT1-mediated choline
uptake in Xenopus oocytes does not completely duplicate the
high-a⁄nity choline uptake of brain synaptosomes.
As hCHT1-mediated choline uptake is both Na- and Cl3-
dependent, the e¡ects of Na and Cl3 on the kinetics of
hCHT1-mediated choline uptake were examined by measuring
choline uptake in oocytes injected with hCHT1 cRNA in the
presence of varying concentrations of extracellular Na or
Cl3. The resulting choline uptake showed a sigmoidal depen-
dence on Na and Cl3 concentration. The dose^response
curve ¢tted to the Hill equation with a Hill coe⁄cient of
2.5, an EC50 of 76 mM, and a Vmax of 0.48 fmol/oocyte/min
(Fig. 4A). The Cl3 data yielded a Hill coe⁄cient of 2.3, an
EC50 of 48 mM, and a Vmax of 0.39 fmol/oocyte/min (Fig.
4B). The apparent EC50 value for Na of hCHT1 was similar
to the values reported for rat brain synaptosomes (40^80 mM)
[6,21]. A Hill coe⁄cient of 2.5 for Na and 2.3 for Cl3 sug-
gest that the transport cycle involves the binding of 2^3 Na
ions and 2^3 Cl3 ions. As choline is a monovalent cation, our
results suggest that the hCHT1-mediated choline uptake is
electrogenic, and both the Na gradient and the inside-nega-
tive membrane potential contribute to the driving force for the
hCHT1-mediated choline uptake.
All the present results indicate that the characteristics of
hCHT1-mediated choline uptake in Xenopus oocytes are es-
sentially the same as those of the high-a⁄nity choline uptake
in human brain synaptosomes. This indicates that hCHT1 is
su⁄cient to exhibit the high-a⁄nity choline uptake activity in
cholinergic nerve terminals. The expression level of hCHT1 in
Xenopus oocytes, as assessed by the [3H]HC3 binding activity,
was 1^5 fmol/oocyte, which is comparable to those of mem-
brane proteins in Xenopus oocytes in usual case (1 fmol/oo-
cyte) [26], indicating that the low uptake activity of oocytes
injected with hCHT1 cRNA is not due to the low expression
level of hCHT1 but due to the low activity of expressed
hCHT1. Actually the turnover rate of hCHT1, 0.1^0.2/s,
was much lower than that of sodium/glucose cotransporter
1, 57/s [27]. The rate of 0.1^0.2/s was also low compared
with the value of 3/s for synaptosomes derived from Torpedo
electric organ [25]. It is interesting to know if there are other
factor(s) which facilitate the uptake activity without changing
the uptake characteristics or if CHT1 has an intrinsic low
uptake activity.
In summary, we have cloned the hCHT1 that is responsible
for high-a⁄nity choline uptake in cholinergic neurons. We
also described the kinetic analysis of hCHT1-mediated choline
uptake in Xenopus oocytes.
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